Multiple Sclerosis Clinical Trials in Phoenix

Showing 481-490 of 490 trials

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

NCT00080197

The purpose of this study is to determine if E7070 is an efficacious, safe, and tolerable treatment for patients with metastatic breast cancer who have failed, or could not tolerate, prior treatments with an anthracycline, a taxane, and capecitabine.

Breast NeoplasmsMetastases

Eisai Inc.250 participantsStarted Feb 2004

Birmingham, Alabama, United States • Hoover, Alabama, United States • Sedona, Arizona, United States +32 more locations

TERMINATEDPhase 2108 miles

Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

NCT00051688

The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor response to the combination of anti-cancer drugs.

Colorectal Neoplasms

Chiron CorporationStarted Jun 2003

Tucson, Arizona, United States • Los Angeles, California, United States • Palm Springs, California, United States +5 more locations

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

Multiple Sclerosis Trials in Other Cities

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Optic Neuritis Treatment Trial (ONTT)

Other Conditions in Phoenix